SYNLAB closes the acquisition of Laboratorio Médico Polanco & Laboratorio Clinicos de Puebla

SYNLAB closes the acquisition of 100 percent of Laboratorio Médico Polanco and Laboratorio Clinicos de Puebla in Mexico

SYNLAB, Europe’s leading medical diagnostic services provider, with a presence in 5 Latin American countries, closes the acquisition of Laboratorio Médico Polanco and Laboratorio Clinicos de Puebla, formely owned by Mexico listed company Medica Sur.

This acquisition marks a clear acceleration in SYNLAB’s regional development. By adding more than 100 diagnostic service points -representing  revenue of around EUR 55 million in 2020¹- and 1,700 skilled employees, including an experienced management team, SYNLAB has now a strong platform to further consolidate the local market.

In August 2021, SYNLAB already closed one additional bolt-on acquisition in Mexico. The acquired business generated around EUR 8 million of revenue in 2020.

SYNLAB has now exceeded its 2021 target for M&A. With a strong and diversified pipeline of future acquisition targets, SYNLAB continues its journey of consolidating the industry.

¹Including COVID-19 testing